SPRED2 and metabolic dysfunction-associated steatohepatitis: Increased serum lipid levels and impaired insulin resistance may cause non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) (46) in Spred2 KO mice.